BridgeBio Pharma
Price & Volume
Stats
See moreOpen | $67.87 |
Previous Close | $68.45 |
Day Range | $66.75-$68.05 |
52W Range | $34.13-$84.94 |
Market Cap | $13.4B |
Shares Short | 24M |
Financials
See moreRevenue (12 Mos) | $579.9M |
Revenue Growth (YoY) | 66.8% |
Gross Profit (12 Mos) | $551.6M |
Diluted EPS | -$3.74 |
News
See moreYahoo Finance • 10 days ago
Citi Initiates BridgeBio at Neutral: Why the Cardiomyopathy Story Isn’t a Slam Dunk
Yahoo Finance • 10 days ago
StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls
Yahoo Finance • 17 days ago
BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1
About
CEO | Dr. Neil Kumar Ph.D. |
CFO | Dr. Thomas Trimarchi Ph.D. |
Address | 3160 Porter Drive, Palo Alto, CA, United States, 94304 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 834 |